Company Profiles

driven by the PitchBook Platform

Acesion Pharma

Description

Developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

2011

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$2.52M

Latest Deal Amount

$3.82M

Total Amount Raised

Description

Developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Website:

www.acesionpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

Ole Maaløes Vej 3 2200 Copenhagen NDenmark +45 2044 2073
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Acesion Pharma's full profile, request a free trial.

Acesion Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Acesion Pharma Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Broadview VenturesVenture CapitalMinority000 0000000 0000
Innovation Fund DenmarkOther000 0000000 0000
NovoCorporate Venture CapitalMinority000 0000000 0000
SEED Capital DenmarkVenture CapitalMinority000 0000000 0000
Wellcome TrustLimited Partner000 0000000 0000
Broadview Ventures Venture Capital
Innovation Fund Denmark Other
Novo Corporate Venture Capital
SEED Capital Denmark Venture Capital
Wellcome Trust Limited Partner

Acesion Pharma Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Ulrik Sørensen Ph.DChief Operating Officer & Co-Founder
Frans Wuite MDChief Executive Officer
Jakob Dynnes HansenChief Financial Officer
Morten Grunnet Ph.DCo-Founder & Chief Scientific Officer & Board Member
Christina SylvestSenior Vice President, Acute Cardioversion
Ulrik Sørensen Ph.D Chief Operating Officer & Co-Founder
Frans Wuite MD Chief Executive Officer
Jakob Dynnes Hansen Chief Financial Officer
Morten Grunnet Ph.D Co-Founder & Chief Scientific Officer & Board Member
Christina Sylvest Senior Vice President, Acute Cardioversion

Acesion Pharma Board Members (6)

NameRepresentingRoleSinceContact
Info
Carsten Schou Ph.DSEED Capital DenmarkGeneral Partner000 0000
Christopher De Souza Ph.DBroadview VenturesDirector000 0000
Ingelise SaundersSelfChairman000 0000
Lars Gredsted Ph.DAcesion PharmaBoard Member000 0000
Paul Goldenheim MDSelfBoard Member000 0000
Carsten Schou Ph.D General Partner SEED Capital Denmark
Christopher De Souza Ph.D Director Broadview Ventures
Ingelise Saunders Chairman Self
Lars Gredsted Ph.D Board Member Acesion Pharma
Paul Goldenheim MD Board Member Self
Request full access to PitchBook